ZBH
Zimmer Biomet Holdings
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: ZBH
- PE Ratio
As of Aug 13, 2026, the Zimmer Biomet Holdings stock's PE ratio is 24.11. This results from the current EPS of $4.13 and stock price of $99.57. The PE ratio marks an increase of 2.9% from the past four quarters average of 23.4.
ZBH PE ratio history
The PE ratio of Zimmer Biomet Holdings has averaged 59.87 over the last ten years. The current P/E ratio of 24.11 is 60% lower than the historical average. In the past ten years, ZBH's PE ratio peaked in the Jun 2020 quarter at 596.8, when the stock price was $119.36 and the EPS was $0.2. The lowest point was in the Mar 2018 quarter, when it reached 13.06 with a price of $109.04 and an EPS of $8.35.
Zimmer Biomet Holdings PE ratio by year
Maximum annual increase: 394.1% in 2015
Maximum annual decrease: -80.07% in 2017
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 25.26 | 6.4% | $89.92 | $3.56 |
| 2024 | 23.74 | -4.24% | $105.63 | $4.45 |
| 2023 | 24.79 | -78.61% | $121.7 | $4.91 |
| 2022 | 115.91 | 76.1% | $127.5 | $1.1 |
| 2021 | 65.82 | N/A | $127.04 | $1.93 |
| 2020 | N/A | N/A | $154.09 | -$0.67 |
| 2019 | 27.12 | N/A | $149.68 | $5.52 |
| 2018 | N/A | N/A | $103.72 | -$1.86 |
| 2017 | 13.44 | -80.07% | $120.67 | $8.98 |
| 2016 | 67.45 | -48.72% | $103.2 | $1.53 |
| 2015 | 131.53 | 394.1% | $102.59 | $0.78 |
| 2014 | 26.62 | 31.39% | $113.42 | $4.26 |
| 2013 | 20.26 | 31.3% | $93.19 | $4.6 |
| 2012 | 15.43 | 16.98% | $66.66 | $4.32 |
| 2011 | 13.19 | -26.76% | $53.42 | $4.05 |
Zimmer Biomet Holdings PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2026 | 20.85 | -10.74% | $86.09 | $4.13 |
| Mar 2026 | 23.36 | -7.52% | $90.42 | $3.87 |
| Dec 2025 | 25.26 | 4.12% | $89.92 | $3.56 |
| Sep 2025 | 24.26 | 9.58% | $98.5 | $4.06 |
| Jun 2025 | 22.14 | -11.37% | $91.21 | $4.12 |
| Mar 2025 | 24.98 | 5.22% | $113.18 | $4.53 |
| Dec 2024 | 23.74 | 15.92% | $105.63 | $4.45 |
| Sep 2024 | 20.48 | -9.06% | $107.95 | $5.27 |
| Jun 2024 | 22.52 | -20.82% | $108.53 | $4.82 |
| Mar 2024 | 28.44 | 14.72% | $131.98 | $4.64 |
| Dec 2023 | 24.79 | -50.07% | $121.7 | $4.91 |
| Sep 2023 | 49.65 | -18.16% | $112.22 | $2.26 |
| Jun 2023 | 60.67 | 0.02% | $145.6 | $2.4 |
| Mar 2023 | 60.66 | -47.67% | $129.2 | $2.13 |
| Dec 2022 | 115.91 | 46.35% | $127.5 | $1.1 |
ZBH Price vs fair value
ZBH average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, ZBH's PE ratio is lower than the 3, 5 and 10-year averages.
PE comparison
With a P/E of 24.11, ZBH stands below the Healthcare sector, the industry and its peers average. But in comparison with its Healthcare sector average of 24.28, Zimmer Biomet Holdings's P/E is only 0.7% lower.
ZBH PE vs peers
Frequently asked questions
What is Zimmer Biomet Holdings's PE ratio?
ZBH stock has a price to earnings ratio of 24.11 as of Aug 13, 2026.
What is the 3-year average PE ratio for Zimmer Biomet Holdings (ZBH)?
The average PE ratio for ZBH stock over the past 3 years is 25.87.
What is the 5-year average PE ratio for Zimmer Biomet Holdings (ZBH)?
The average PE ratio for ZBH stock over the past 5 years is 47.36.
What is the highest PE ratio for ZBH?
Over the last ten years, the quarterly PE ratio reached a historic high of 596.8 in the Jun 2020 quarter.
How does the current PE ratio for ZBH compare to its historical average?
ZBH's price to earnings ratio is currently 60% below its 10-year historical average.
How is ZBH's PE ratio calculated (Zimmer Biomet Holdings PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Aug 13, 2026), Zimmer Biomet Holdings's stock price is $99.57. The earnings per share for the trailing twelve months (TTM) ending Jun 2026 is $4.13. Therefore, Zimmer Biomet Holdings's PE ratio for today is 24.11. PE RATIO(24.11) = STOCK PRICE($99.57) / TTM EPS($4.13)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.